Bank of America Corp DE Sells 10,847 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Bank of America Corp DE cut its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 34.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 20,513 shares of the company's stock after selling 10,847 shares during the quarter. Bank of America Corp DE owned about 0.05% of Phibro Animal Health worth $431,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Aquatic Capital Management LLC purchased a new stake in shares of Phibro Animal Health in the 4th quarter worth about $69,000. Quantbot Technologies LP lifted its holdings in Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after purchasing an additional 2,018 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Phibro Animal Health in the 4th quarter valued at about $113,000. New York State Teachers Retirement System lifted its holdings in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares in the last quarter. Finally, Nebula Research & Development LLC purchased a new position in Phibro Animal Health in the 4th quarter valued at about $210,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Performance

PAHC stock traded down $0.58 during mid-day trading on Friday, reaching $23.93. The company had a trading volume of 152,026 shares, compared to its average volume of 205,137. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The stock has a market capitalization of $969.98 million, a P/E ratio of 49.85, a P/E/G ratio of 0.45 and a beta of 0.74. Phibro Animal Health Co. has a one year low of $16.16 and a one year high of $26.55. The stock's 50-day simple moving average is $21.25 and its two-hundred day simple moving average is $21.89.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The business had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Research analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.01%. Phibro Animal Health's payout ratio is 61.54%.

Analyst Upgrades and Downgrades

PAHC has been the topic of several recent analyst reports. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Morgan Stanley increased their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday, May 8th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $20.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.